A Cyclic AMP Response Element in the Angiotensin-converting Enzyme Gene and the Transcription Factor CREM Are Required for Transcription of the mRNA for the Testicular Isozyme*

Sean P. KesslerDagger , Theresa M. RoweDagger , Julie A. Blendy§, Robert P. Erickson, and Ganes C. SenDagger par

From the Dagger  Department of Molecular Biology, The Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, the § Department of Pharmacology, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, and the  Departments of Pediatrics and Molecular and Cellular Biology, University of Arizona, College of Medicine, Tucson, Arizona 85724

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The angiotensin-converting enzyme (ACE) gene produces two mRNA species from tissue-specific promoters. The transcription start site of the mRNA for the smaller testicular isozyme (ACET) is located within an intron of the larger transcription unit that encodes the pulmonary isozyme (ACEP).We have previously demonstrated that a 298-base pair DNA fragment, 5' to the rabbit ACET mRNA transcription initiation site, can activate the testicular expression of a transgenic reporter gene. In the current study, using the same transgenic reporter system, we identified a putative cyclic AMP response element present within this DNA fragment to be absolutely essential for transcriptional activation. Moreover, we observed that ACET mRNA was not expressed in the testes of mice homozygous for a null mutation in the transcription factor CREM. However, in the same mice, ACEP mRNA was abundantly expressed in the lung. Our observations indicate that ACET mRNA expression in the testes is regulated by the putative cyclic AMP response element present 5' to the transcription start site and the corresponding transcription factor CREM.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Angiotensin-converting enzyme (ACE)1 is a carboxyl-terminal dipeptidyl exopeptidase that converts angiotensin I to angiotensin II, a potent vasopressive hormone (1). The two isoforms of ACE, ACEP and ACET, have identical enzymatic activity and are encoded by distinct mRNAs transcribed from the same gene through tissue-specific choice of transcription initiation and polyadenylation sites (2-4). The genomic organization is such that the ACET transcription unit is nested within the ACEP transcription unit (5-7). In addition, the first exon of ACET mRNA is unique to the ACET transcription unit. The ACET promoter and first ACET exon reside in the 12th ACEP intron, which is spliced out of the primary ACEP transcript (2, 8). Rabbit ACEP is a glycoprotein of 140 kDa and is produced by vascular endothelial cells, intestinal brush-border cells, renal proximal tubular cells, monocytes, and Leydig cells (9-14). The ACET isoform has a molecular mass of 100 kDa and is produced exclusively in adult testis by developing sperm cells, specifically late pachytene spermatocytes (13, 15).

We have previously demonstrated that the 5' proximal 298 bp of DNA upstream of the ACET transcription initiation site are sufficient to provide correct tissue-specific expression of the rabbit ACET message (8). Within this region lies a cyclic AMP response element-like site (CRET) at -52 and a TATA-like binding site at -27, which are homologous to the murine ACET CRE-like and TATA-like sites (8). It was previously reported that the ACET TATA sequence binds TATA-binding protein from non-testicular nuclear extracts. In addition, mutation of the ACET promoter TATA-like element to a consensus TATA sequence did not alter the testes-specific gene expression in transgenic mice (16). These data suggest that the ACET TATA-like site is not responsible for tissue-specific expression of ACET mRNA, and the focus should be directed at the role of CRET in ACET gene transcription.

Cyclic AMP response in differentiating sperm cells is mediated by the CREM gene family. All members contain a CRE binding domain and a kinase-inducible domain that is phosphorylated by cAMP-activated cyclic AMP-dependent protein kinase. CREM isoforms differ in their ability to stimulate or repress transcription due to the presence (CREMtau ) or absence (CREMalpha ) of glutamine-rich domains (17). In addition, CREM isoform transcriptional effects are gene, cell-type, and promoter specific (18). Though immature sperm cells contain both isoforms at low levels, differentiated sperm cells contain markedly increased levels of CREMtau protein (19, 20). The physiological importance of CREM has recently been demonstrated through murine gene-targeting methodologies (21). Male mice devoid of all CREM isoforms are sterile due to dramatic reduction in post-meiotic sperm-specific gene expression and failed spermatogenesis. Transcription of protamine 1, protamine 2, TP1, TP2, calspermin, Krox-20, Kox-24, proacrosin, MCS, and RT7 genes was absent in CREM -/- mice (21, 22). There is no other phenotypic alteration of the physiology of these male mice nor in homozygous CREM mutant females that retain fertility (21). The ACET CRET binds both CREMtau and CREMalpha proteins and directs proper cAMP stimulation of a heterologous promoter in vitro (18).

In the current study, we investigated the role of the CRET site in directing ACET mRNA transcription by mutating this site in a transgenic reporter gene that is expressed in sperm cells. In addition, we assessed the role of the CREM family of transcription factors, in ACE gene expression, by measuring the levels of the two mRNAs in different tissues of CREM -/- mice. Our results showed that both the cis-element CRET and the transacting factor CREM are necessary for sperm-specific expression of ACET mRNA.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- DNA-modifying enzymes were purchased from Life Technologies, Inc. or Boehringer Mannheim. Oligonucleotides were purchased from Operon Technologies, Inc. All radioisotopes were purchased from NEN Life Science Products. Total RNA was isolated and prepared from tissues (brain, kidney, lung, and testes) of wild type (+/+) or homozygous (-/-) CREM mutant adult mice as described previously (21). The p-TRI-cyclophilin-mouse antisense control template was purchased from Ambion Inc. RNAzol B was purchased from Tel-Test, Inc.

Plasmid Construction-- The -298 ACET gene promoter was mutated utilizing the Muta-Gene phagemid in vitro mutagenesis system (Bio-Rad) and the oligonucleotide rACETCREMN (CCTGCAGTGTGTCCGCATAGAGCAG). Mutagenesis was confirmed by sequencing. The mutated ACET promoter was cloned into PSVOCAT to yield pACET-CRENull (23). The ACE probe used for ribonuclease protection assay (RPA) was cloned by reverse transcriptase-polymerase chain reaction utilizing 1 µg of total mouse testes RNA, the mouse ACE -2A (TCTGAAGCTTCTTTATGATCC), and the mouse ACE-1S (ATGGGCCAAGGTTGGGCTA) oligonucleotides. The polymerase chain reaction product was subcloned into pBlueScript KS to yield plasmid PM045.

Transgenic Mice-- The pACET-CRENull plasmid was digested with XbaI and BamHI to release the 2.03-kilobase DNA fragment illustrated in Fig. 1. The DNA fragment was injected into C57BL/6JXSJL/J F2 zygotes by standard techniques (8). Positive transgenics and their progeny were identified by Southern blot hybridization.

Southern Blot Hybridization-- Mouse genomic DNA (15 µg) was digested with HindIII and ScaI or BanI. The samples were electrophoresed through a 0.8% agarose gel in TBE and transferred to HybondTM-N+ (Amersham Pharmacia Biotech) in 0.4 N NaOH. The membrane was prehybridized in 20 ml of C buffer (0.5 M NaPO4, pH 7.2, 7% SDS, 1% bovine serum albumin, 1 mM EDTA, 250 µg/ml denatured salmon sperm DNA) for 2 h at 65 °C. The 551-bp CAT gene probe was released from PSVOCAT by HindIII and NcoI digestion and radiolabeled as described in the random-primed DNA labeling kit (Boehringer Mannheim). The denatured probe was added to 20 ml of C buffer. The membrane was hybridized for 16 h at 65 °C and then washed as follows: solution 1 (40 mM NaPO4, pH 7.2, 5% SDS, 0.5% bovine serum albumin, 1 mM EDTA) for 30 min at 25 °C and 30 min at 55 °C, and solution 2 (40 mM NaPO4, pH 7.2, 1% SDS, 1 mM EDTA) for 30 min at 57 °C.

For copy number determination, the BanI-digested CAT gene-probed membrane was exposed to a PhosphorImager screen, stripped, and rehybridized with the 450-bp ACE probe. The washing conditions were as follows: solution 1 for 30 min at 25 °C and 56 °C for 30 min, and solution 2 for 30 min at 58 °C. The membrane was re-exposed to the PhosphorImager screen. Each CAT mRNA signal was normalized to the ACE-specific mRNA signal using ImageQuant software.

Chloramphenicol Acetyltransferase Assay-- Tissues were analyzed according to previously described methods (8, 23). Fifty micrograms of protein was assayed for 2 h at 37 °C. The samples were spotted on a TLC plate and resolved in a 95:5 (v/v) chloroform to methanol solvent system. The radiolabeled acetylated chloramphenicol was visualized by autoradiography.

Ribonuclease Protection Assay-- Total mRNA was isolated from CREM +/+ and CREM -/- mouse tissues using the RNAzol B system according to the manufacturer's instructions. The cyclophilin probe was transcribed from the p-TRI-cyclophilin-mouse antisense control template (Ambion Inc., Austin, TX) to generate a 165-bp riboprobe. The 470-bp ACE probe was transcribed from the plasmid PM045 described above. The assay was performed as described (24). Antisense RNA was transcribed in vitro using T7 RNA polymerase (Boehringer Mannheim), ATP, CTP, GTP, and [alpha -32P]UTP (800 Ci/mmol) (NEN Life Science Products). Riboprobe containing 1.0 × 105 Cerenkov counts was hybridized overnight at 45 °C with 5.0 µg of total RNA from CREM +/+ and -/- mouse brain, kidney, lung, and testes in 30 µl of hybridization buffer (40 mM PIPES, pH 6.4, 400 mM NaCl, 1 mM EDTA, pH 8.0, 80% formamide). Following hybridization, the probe was digested with 40 µg/ml RNaseA (Boehringer Mannheim) and 2 µg/ml RNase T1 (Boehringer Mannheim) in 400 µl of ribonuclease digestion buffer (10 mM Tris-Cl, pH 7.5, 5 mM EDTA, 300 mM NaCl) for 1 h at 30 °C. Samples were then incubated with 100 µg of proteinase K and 0.5% SDS for 20 min at 37 °C. The products were extracted, loaded onto a 6% polyacrylamide, 8 M urea gel, and visualized by autoradiography. The mRNA levels were determined by PhosphorImager analysis using ImageQuant software.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Mutation of the CRET Site-- Previous reports have implicated the ACET CRE-like site (CRET) as being a putative positive regulator of ACET expression (18, 25). The 298-bp rabbit ACET promoter, which gave correct tissue-specific reporter gene expression in transgenic mice, contains a CRE-like site (CRET) (8). To study the role of this CRET site, we utilized site-directed mutagenesis to alter the normal ACET CRET (TGAGGTCA) to a null-CRE site (TGCGGACA) (Fig. 1A). We have previously demonstrated that this mutation abolishes the binding of CREM isoforms tau  and alpha  to the altered CRE site in gel mobility shift assays (18). Four independent ACET-CRENull mouse lines were established by injecting the DNA fragment illustrated (Fig. 1A) into C57BL/6JXSJL/J F2 zygotes. Positive transgenics and their progeny were confirmed by Southern blot (Fig. 1B). Genomic DNA from mouse 5090 (line A), 5091 (line C), 5108 (line D), and 5066 (line E) was digested with HindIII and ScaI, which releases a 701-bp CAT gene fragment (Fig. 1B). The probe was the 551-bp HindIII right-arrow NcoI CAT gene fragment (Fig. 1A). To verify that the ACET-CRENull promoter and CAT gene integrated intact, the genomic DNA was digested with BanI (Fig. 1A) and reprobed with the HindIII right-arrow NcoI CAT gene probe (Fig. 1C). The transgene copy number of each line was determined as described under "Experimental Procedures." Both CAT and ACE probes had the same specific activity. The signals from the CAT hybridization were normalized to the ACE-specific signal obtained in the mouse ACE hybridization. The approximate copy number for each line was as follows: line A, 35-40; line C, 30-35; line D, 5-10; and line E, 320-330 (Fig. 1C).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   Southern hybridization of the ACET-CRENull CAT transgenic lines A, C, D, and E. A, the 2.03-kilobase XbaI-BamHI fragment is identical to the previously reported pACET-CAT2 transgene except that the CRET sequence (TGAGGTCA) at -52 was mutated to the null sequence (TGCGGACA) (8). The HindIII-NcoI CAT gene fragment used for Southern hybridization is also indicated along with the BanI, HindIII, and ScaI sites used for mouse genomic DNA digestion. B, 15 µg of mouse genomic DNA (normal (N) and lines A, C, D, and E) digested with HindIII and ScaI released a 701-bp CAT gene fragment from the transgenic lines A, C, D, and E. The probe is the 551-bp HindIII-NcoI CAT gene fragment from PSVOCAT. The CAT lane contains 25 pg of ACET-CRENull CAT plasmid DNA digested with HindIII and ScaI. C, 15 µg of mouse genomic DNA (N, A, C, D, and E) digested with BanI released a 966-bp fragment from the four transgenic lines A, C, D, and E. The CAT lane contains 25 pg of ACET-CRENull CAT plasmid digested with BanI. The copy number of each line was determined by stripping the blot in C and reprobing with the 450-bp mouse ACE cDNA probe and comparing the signals of the transgene and the mouse ACE gene.

Chloramphenicol Acetyltransferase Assay on Transgenic Mice Tissue-- The testicular isoform of ACE is expressed exclusively in sperm (13, 15). Previously, we reported that the -298 ACET promoter drives CAT gene expression confined to the testes of the mouse containing the pACET-CAT2 transgene (8). When the ACET-CRENull mice were assayed for transgene expression, no CAT activity was observed in the testes of any of the four lines (Fig. 2). Our positive controls were testes extract from the pACET-CAT 2, line F (mouse 2010) (8), and purified CAT enzyme. To determine if the CRENull mutation causes ubiquitous CAT expression, we assayed CAT activity in the lung, kidney, brain (Fig. 2) spleen, and liver (data not shown). All tissues tested were negative for CAT activity.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 2.   Chloramphenicol acetyltransferase assay on ACET-CRENull CAT mouse tissue. Fifty micrograms of soluble protein was assayed for CAT activity as described under "Experimental Procedures." Radiolabeled acetylated chloramphenicol was analyzed by TLC and visualized by autoradiography. A, the control sample is 50 µg of testes protein from the previously reported pACET-CAT 2, line F transgenic mouse, which contains the wild type CRET sequence at -52 and yields testes-specific CAT expression (8). B, purified CAT enzyme served as the control for this TLC. For both TLC plates, the transgenic line tissues are abbreviated as follows: B, brain; K, kidney; L, lung; T, testes; and N, no tissue.

Ribonuclease Protection Assay on CREM Knock-out Mice-- Having established that mutation of the CRET site abolishes rabbit ACET promoter function in transgenic mice testes, we focused on the trans-acting factors that bind to the CRET site (18). To address this point, we studied the endogenous ACE expression in a mouse devoid of all CREM isoforms. The method used to knock out the CREM gene disrupts the coding region of all CREM family members (21). Total RNA was isolated from age-matched CREM +/+ and CREM -/- mouse brain, kidney, lung, and testes. The mouse ACET mRNA level in each of these tissues was determined by RPA utilizing a mouse ACE probe that distinguishes between mouse ACEP mRNA and mouse ACET mRNA levels (Fig. 3). This 470-bp mouse ACE antisense RNA probe was produced by transcribing mouse cDNA containing ACET-specific exon 12T and ACET and ACEP shared exons 13 and 14. The protected ACET message was 450 bp due to the protection of the 12T exon present in normal ACET mRNA. The protected ACEP message was 260 bp due to the absence of the 12T exon in the normal ACEP mRNA (Fig. 3A). This assay clearly demonstrated that the ACET message was absent in CREM -/- testes (Fig. 3C). To confirm the integrity of the testicular total RNA preparation, a mouse cyclophilin RNA probe was included in the RPA. No decrease in cyclophilin mRNA level was observed in CREM -/- testes. The levels of ACEP mRNA was not reduced in CREM -/- brain, kidney, and lung (Fig. 3, B and C). However, we did observe a reduction in the ACEP message in CREM -/- testes (Fig. 3C).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 3.   Ribonuclease protection assay on tissues from a normal and CREM -/- mouse. A, the full-length mouse ACE cDNA probe (470 bp) consists of ACET exon 12T and exons 13 and 14, which are common to both ACEP and ACET mRNAs. B and C, 5 µg of total RNA isolated from the brain, kidney, lung, and testes of a normal (+/+) and CREM knock-out (-/-) mice were hybridized with 32P-labeled ACE (470 bp) and cyclophilin (165 bp) antisense RNA probes. Following RNase digestion, the protected RNA probes (ACEP, 260 bp; ACET, 450 bp; and cyclophilin, 103 bp) were resolved in a 6% polyacrylamide, 8 M urea gel and visualized by autoradiography. The ACE probe consists of mouse ACE exon 12T, which is unique to the ACET mRNA, and exons 13 and 14, which are common to both ACET and ACEP mRNAs.

To determine the extent of reduction of ACET mRNA levels, we quantitated the RPA on CREM +/+ and CREM -/- lung and testes in Fig. 3C. The protected ACEP, ACET, and cyclophilin mRNA signals were quantitated by PhosphorImager analysis. The ACEP and ACET mRNA levels were normalized to the cyclophilin mRNA signals (Table I). Both ACET and ACEP mRNA were highly expressed in the testes of the CREM +/+ mouse, whereas only the ACEP mRNA was expressed in the lung. In the CREM -/- mouse, no ACET mRNA was detectable in the testes. Surprisingly, although ACEP mRNA expression in the lungs of the CREM -/- mouse was comparable with that of the CREM +/+ mouse, ACEP mRNA expression in the testes of the CREM -/- mouse was also drastically inhibited.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Quantitation of ACET and ACEP mRNAs in a normal and CREM -/- mouse
Five micrograms of total RNA isolated from lung and testes of a normal (+/+) and CREM knock-out (-/-) mice were assayed as described in Fig. 3. Following electrophoresis, the gel was dried and exposed to a Molecular Dynamics PhosphorImager screen. Protected 260-bp ACEP, 450-bp ACET, and 103-bp cyclophilin signals were quantitated with the ImageQuant software. The table indicates the relative ACET or ACEP mRNA levels achieved by normalizing each protected probe signal to the cyclophilin signal. The highest relative mRNA level (ACEP in testes) was set equal to 100%.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In this study, we investigated the mechanism of testis-specific expression of the ACET mRNA. In adult males, this mRNA is exclusively expressed in maturing sperm cells, although the ACEP mRNA, which arises from the same gene, is expressed in many other tissues (9-15). Using tissue-cultured cells, the rabbit ACEP transcription unit has been extensively analyzed, and the presence of several positive regulatory sites and a strong silencer element has been noted (26-28). For analyzing the transcriptional promoter of the ACET transcription unit, we had to resort to a transgenic assay system because the relevant sperm cells cannot be cultivated in vitro. Using a CAT reporter gene, we previously demonstrated that a 298-bp fragment upstream of the rabbit ACET mRNA transcription start site is capable of driving testis-specific and developmentally regulated expression of CAT (8). Among several putative regulatory sites present within this region is the CRET element, which resembles a consensus cyclic AMP response element (29). Using in vitro assays, we demonstrated that this site is capable of binding to the CREM transcription factors and initiating their transcriptional stimulatory effects (18). In the current study, we investigated whether the above observations are also true in vivo in the ACET-expressing adult testes. For this purpose, we used a combination of transgenic and gene knock-out mice.

Results from the CRENull transgenic mice clearly showed that the CRET site is necessary for in vivo functioning of the ACET promoter. Five independent CRENull transgenic lines (line B and data not shown) failed to express the reporter gene in adult testes. Although earlier studies have suggested that the CRET site is functional in vitro (16, 18, 25), the current study has demonstrated its absolute requirement in the context of the ACET promoter functioning in vivo. Because the CREM gene family of cAMP-activating transcription factors has been shown to be important for sperm gene expression, we examined the ACE mRNA expression profile in CREM -/- mice (21, 22). Like several other cAMP-dependent testicular mRNAs, ACET mRNA expression was totally absent in CREM -/- cells. These results strongly suggest that CREM is the relevant physiological transcription factor that binds to the CRET site of the ACE gene and activates transcription of the ACET mRNA.

Although the results presented here provide an understanding of the mechanism of activation of the ACET promoter, it is still not clear why this transcription unit is not activated in other tissues. Why is the CRET site not recognized by any of the multiple cAMP-activated transcription factors (e.g. CREM, CREB, c/EBP, etc.) and the ACET mRNA transcribed? CREB is more abundant in lung and kidney than CREM and is capable of binding to the ACET CRE site to activate transcription (30). Alternatively, does active transcription of the ACEP mRNA preclude the use of the ACET promoter in some way?

Our results revealed another apparent anomaly. ACEP mRNA is normally expressed in vascular endothelial cells and Leydig cells of the testes (9, 13). However, ACEP mRNA was poorly transcribed in the testes, but not the lung, of the CREM -/- mouse. It was not due to a global deficiency in transcription because many mRNAs, including the cyclophilin mRNA that was used as an internal control in our experiment, were transcribed normally in the same tissue. In addition, CREM -/- mutant mice possess normally developed Sertoli and Leydig cells (22). Does that mean that ACET and ACEP mRNA transcription in the testes are somehow coupled? This may be the case, albeit indirectly, if the decreased expression of ACEP mRNA in the CREM -/- mice reflects the dependence of its expression on paracrine factors in the testis. Cultures of Sertoli cells, with and without germ cells, have suggested that spermatocytes and early spermatids may have important regulatory influences on Sertoli cells (31). In turn, there is abundant evidence that Sertoli cell factors modulate Leydig cell steroidogenesis. These influences have been thought to be both positive and negative, depending on the study (32). This suggests that although mature sperm-deficient CREM -/- mice have Leydig cells that appear normal (22), perhaps their ability to produce ACEP mRNA is impaired. Therefore, ACEP mRNA levels in the testes would be more dependent on sperm cell development as a whole rather than directly on ACET expression itself. It is also possible that CREM proteins are directly needed for ACEP mRNA transcription as well. However, that requirement must be obviated in the lung. No clear-cut explanation emerges from the available information, and further investigations will be required for resolving these issues.

    ACKNOWLEDGEMENTS

We gratefully acknowledge Diana Davis and Sean Pocock for assistance with the CRENull transgenic mouse lines and Paul Stanton for site-directed mutagenesis techniques. We thank the members of the GCS laboratory for helpful discussions.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grant HL-48258 and by a fellowship from the American Heart Association, Northeast Ohio Affiliate. The University of Arizona transgenic facility is partially supported by Cancer Center Support Grant P30 CA23074 and Southwest Environmental Health Sciences Center Grant P30 ES06694.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

par To whom correspondence should be addressed: Dept. of Molecular Biology, The Cleveland Clinic Foundation, 9500 Euclid Ave., NC20, Cleveland, OH 44195. Tel.: 216-444-0636; Fax: 216-444-0512.

1 The abbreviations used are: ACE, angiotensin-converting enzyme; ACET, testicular angiotensin-converting enzyme; ACEP, pulmonary angiotensin-converting enzyme; CRE, cyclic AMP response element; CAT, chloramphenicol acetyltransferase; CREM, cyclic AMP response element modulator; RPA, ribonuclease protection assay; bp, base pair(s); PIPES, 1,4-piperazinediethanesulfonic acid.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Soffer, R. L. (1981) in Biochemical Regulation of Blood Pressure (Soffer, R. L., ed), pp. 123-164, Wiley-Interscience, New York
  2. Kumar, R. S., Kusari, J., Roy, S. N., Soffer, R. L., and Sen, G. C. (1989) J. Biol. Chem. 264, 16754-16758[Abstract/Free Full Text]
  3. Kumar, R. S., Thekkumkara, T. J., and Sen, G. C. (1991) J. Biol. Chem. 266, 3854-3862[Abstract/Free Full Text]
  4. Thekkumkara, T. J., Livingston, W. D., Kumar, R. S., and Sen, G. C. (1992) Nucleic Acids Res. 20, 683-687[Abstract]
  5. Bernstein, K. E., Martin, B. M., Edwards, A. S., and Bernstein, E. A. (1989) J. Biol. Chem. 264, 11945-11951[Abstract/Free Full Text]
  6. Ehlers, M. R., Fox, E. A., Strydom, D. J., and Riordan, J. F. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7741-7745[Abstract]
  7. Soubrier, F., Alhenc-Gelas, F., Hubert, C., Allegrini, J., John, M., Tregear, G., and Corvol, P. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 9386-9390[Abstract]
  8. Erickson, R. P., Kessler, S. P., Kremling, H., and Sen, G. C. (1996) Mol. Reprod. Dev. 44, 324-331[CrossRef][Medline] [Order article via Infotrieve]
  9. Berg, T., Sulner, J., Lai, C. Y., and Soffer, R. L. (1986) J. Histochem. Cytochem. 34, 753-760[Abstract]
  10. Brentjens, J. R., Matsuo, S., Andres, G. A., Caldwell, P. R., and Zamboni, L. (1986) Experientia 42, 399-402[Medline] [Order article via Infotrieve]
  11. Caldwell, P. R., Seegal, B. C., Hsu, K. C., Das, M., and Soffer, R. L. (1976) Science 191, 1050-1051[Medline] [Order article via Infotrieve]
  12. Friedland, J., Setton, C., and Silverstein, E. (1978) Biochem. Biophys. Res. Commun. 83, 843-849[Medline] [Order article via Infotrieve]
  13. Langford, K. G., Zhou, Y., Russell, L. D., Wilcox, J. N., and Bernstein, K. E. (1993) Biol. Reprod. 48, 1210-1218[Abstract]
  14. Patchett, A. A., and Cordes, E. H. (1985) Adv. Enzymol. Relat. Areas Mol. Biol. 57, 1-84[Medline] [Order article via Infotrieve]
  15. El-Dorry, H. A., Bull, H. G., Iwata, K., Thornberry, N. A., Cordes, E. H., and Soffer, R. L. (1982) J. Biol. Chem. 257, 14128-14133[Abstract/Free Full Text]
  16. Zhou, Y., Overbeek, P. A., and Bernstein, K. E. (1996) Biochem. Biophys. Res. Commun. 223, 48-53[CrossRef][Medline] [Order article via Infotrieve]
  17. Delmas, V., Laoide, B. M., Masquilier, D., de Groot, R. P., Foulkes, N. S., and Sassone-Corsi, P. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 4226-4230[Abstract]
  18. Goraya, T. Y., Kessler, S. P., Stanton, P., Hanson, R. W., and Sen, G. C. (1995) J. Biol. Chem. 270, 19078-19085[Abstract/Free Full Text]
  19. Foulkes, N. S., Mellstrom, B., Benusiglio, E., and Sassone-Corsi, P. (1992) Nature 355, 80-84[CrossRef][Medline] [Order article via Infotrieve]
  20. Foulkes, N. S., Schlotter, F., Pevet, P., and Sassone-Corsi, P. (1993) Nature 362, 264-267[CrossRef][Medline] [Order article via Infotrieve]
  21. Blendy, J. A., Kaestner, K. H., Weinbauer, G. F., Nieschlag, E., and Schutz, G. (1996) Nature 380, 162-165[CrossRef][Medline] [Order article via Infotrieve]
  22. Nantel, F., Monaco, L., Foulkes, N. S., Masquilier, D., Le Meur, M., Henriksen, K., Dierich, A., Parvinen, M., and Sassone-Corsi, P. (1996) Nature 380, 159-162[CrossRef][Medline] [Order article via Infotrieve]
  23. Gorman, C. M., Moffat, L. F., and Howard, B. H. (1982) Mol. Cell. Biol. 2, 1044-1051[Medline] [Order article via Infotrieve]
  24. Ausubel, F. B., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (1993) Current Protocols in Molecular Biology, pp. 4.7.1-4.7.8, Current Protocols, Boston
  25. Howard, T., Balogh, R., Overbeek, P., and Bernstein, K. E. (1993) Mol. Cell. Biol. 13, 18-27[Abstract]
  26. Goraya, T. Y., Kessler, S. P., Kumar, R. S., Douglas, J., and Sen, G. C. (1994) Nucleic Acids Res. 22, 1194-1201[Abstract]
  27. Kessler, S. P., and Sen, G. C. (1995) Cell. Mol. Biol. Res. 41, 595-602[Medline] [Order article via Infotrieve]
  28. Kessler, S. P., Goraya, T. Y., and Sen, G. C. (1996) Gene Expr. 6, 73-85[Medline] [Order article via Infotrieve]
  29. Lalli, E., and Sassone-Corsi, P. (1994) J. Biol. Chem. 269, 17359-17362[Free Full Text]
  30. Zhou, Y., Sun, Z., Means, A. R., Sassone-Corsi, P., and Bernstein, K. E. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 12262-12266[Abstract/Free Full Text]
  31. Jegou, B., and Sharpe, R. M. (1993) Molecular Biology of the Male Reproductive Tract, pp. 271-310, Academic Press, New York
  32. Risbridger, G. P., and de Kretser, D. M. (1989) The Testis, 2nd Ed., pp. 255-268, Raven Press, New York


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.